RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-1150
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_1113400; Gene model (P.falciparum): PF3D7_0513700; Gene product: secreted ookinete protein, putative | 6-cysteine protein (secreted ookinete protein, putative; PSOP12)
Name tag: EGFP
Phenotype Gametocyte/Gamete; Fertilization and ookinete;
Last modified: 14 January 2015, 14:15
  *RMgm-1150
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging
Reference (PubMed-PMID number) Reference 1 (PMID number) : 25454088
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 2.34
Other information parent lineP. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943).
The mutant parasite was generated by
Name PI/ResearcherSala, KA; Blagborough AM
Name Group/DepartmentDepartment of Life Sciences
Name InstituteSir Alexander Fleming Building, Imperial College
CityLondon
CountryUK
Name of the mutant parasite
RMgm numberRMgm-1150
Principal namePbPSOP12-EGFP
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationNo
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteExpression of the GFP-tagged PSOP12 exclusively in gametocytes, gametes and ookinetes.
Fertilization and ookineteExpression of the GFP-tagged PSOP12 exclusively in gametocytes, gametes and ookinetes.
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses a C-terminal GFP-tagged version of PSOP12

Protein (function)
The protein was detected in a proteome analysis of ookinetes and contains a predicted signal sequence. PSOP12 is a putative member of the well-characterized 6-Cys family of proteins. PSOP12 has been previously identified in a reverse genetics screen and medium-throughput knockout study in P. berghei, and was demonstrated as expressed in the ookinete. Expression of the protein is predicted in both the P. berghei gametocyte and ookinete. A signal peptide is located at amino acids 1–24.
Multiple gene knockouts of psop12 (RMgm-89, RMgm-254) have resulted in no detectable phenotype in blood-, sexual-, liver or pre-erythrocytic stages, suggesting that the protein could have a non-essential function within the parasite lifecycle.

Phenotype
Expression of the GFP-tagged PSOP12 exclusively in gametocytes, gametes and ookinetes

Additional information
In all stages where expression was observed much of the fluorescence signal emanated from the cell periphery, suggesting localization to the plasmalemma. This was further confirmed by IFA on fixed parasites performed with anti-EGFP mAb under non-permeablizing conditions,which demonstrated surface staining in the gametes and ookinetes. Identical surface staining was noted in transgenic PbPSOP12-EGFPparasites, and in WT P. berghei parasites stained with anti-BDES-PbPSOP12-spider serum, confirming the localization of  PbPSOP12on the surface of the sexual/ookinete stages of the parasite, whilst suggesting that the presence of the EGFP-fusion protein in the transgenic line does not alter the native localization of the protein.Staining in the zygote was not observed.

In this study it was shown that immunisation of mice with PSOP12 (expressed in the baculovirus dual expression system) induces anti-malarial transmission blocking immunity.

Other mutants
Multiple gene knockouts of psop12 (RMgm-89, RMgm-254) have resulted in no detectable phenotype in blood-, sexual-, liver or pre-erythrocytic stages


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1113400
Gene Model P. falciparum ortholog PF3D7_0513700
Gene productsecreted ookinete protein, putative | 6-cysteine protein
Gene product: Alternative namesecreted ookinete protein, putative; PSOP12
Details of the genetic modification
Name of the tagEGFP
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid single cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe PbPSOP12-GFP transgenic line was created, introducing a C-terminal GFP tag to the native by single homologous recombination. The targeting construct pPbPSOP12-GFP was constructed using the backbone of the EGFP-tagging vec-tor p277. The terminal 1351 bp of the psop12 gene(PBANKA 111340) was amplified by PCR, using the oligos PS1 (5'-GGTACCGGATATTTCAAAAATCAGAGGATATTATATATCAATTATTTC-3') and PS2 (5'-GGGCCCAACGAATGTGTAGGTAATTTCGTATAGGATG-3'), with flanking KpnI and ApaI sites introduced (underlined) to the amplicon. The resulting fragment was cloned in frame into the ApaI/KpnI site of p277, resulting in pPbPSOP12-GFP. For transfection, this construct was linearized at a naturally occurring BclI site within the psop12 sequence.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6